Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00279656|
Recruitment Status : Completed
First Posted : January 19, 2006
Last Update Posted : January 19, 2006
|Condition or disease||Intervention/treatment||Phase|
|Frail Elderly Inpatient||Behavioral: Pharmaceutical care||Phase 4|
Widespread evidence reveals frequent inadequate use of medicines in elderly patients. This includes inappropriate prescribing (overuse, underuse, misuse) that can lead to adverse drug events and drug-related admissions to hospital. In addition, when a patient is transferred from acute care settings to ambulatory care settings, discrepancies in medicines used often occur and can be hazardous.
Despite this, only limited data exist on the effectiveness of optimization strategies targeted at frail elderly inpatients.
Comparison: elderly inpatients receiving geriatric evaluation and management (GEM) care versus elderly inpatients receiving pharmaceutical care in addition to GEM care.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||180 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients - Randomized Controlled Trial|
|Study Start Date :||November 2003|
|Study Completion Date :||June 2005|
- Appropriateness of prescribing (using the Medication Appropriateness Index, the Beers criteria, and the ACOVE criteria of underuse) on admission, at discharge, and 3 months post-discharge
- Polymedication on admission, at discharge, and 1,3,12 months after discharge
- Mortality, readmission to hospital and visit to the emergency department 1,3,12 months after discharge
- Satisfaction with information received on medicines
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00279656
|Université catholique de Louvain|
|Brussels, Belgium, 1200|
|Principal Investigator:||Anne Spinewine, MSc||Université Catholique de Louvain|
|Study Chair:||Christian Swine, MD||Université Catholique de Louvain|
|Study Director:||Paul M Tulkens, PhD||Université Catholique de Louvain|